Detalles de la búsqueda
1.
COVID-19: using chest CT of major trauma patients to monitor and evaluate the second wave in London and the development of routine monitoring in practice.
Clin Radiol
; 77(3): 231-235, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35022132
2.
An analysis of screen-detected invasive cancers by grade in the English breast cancer screening programme: are we failing to detect sufficient small grade 3 cancers?
Eur Radiol
; 31(4): 2548-2558, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32997179
3.
COVID-19: using chest CT of major trauma patients to monitor and evaluate the effect of lockdown and the importance of household size.
Clin Radiol
; 76(5): 374-378, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33637312
4.
COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London.
Clin Radiol
; 76(1): 74.e15-74.e21, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33246570
5.
An analysis of 11.3 million screening tests examining the association between recall and cancer detection rates in the English NHS breast cancer screening programme.
Eur Radiol
; 29(7): 3812-3819, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30715589
6.
Correction to: An analysis of 11.3 million screening tests examining the association between recall and cancer detection rates in the English NHS breast cancer screening programme.
Eur Radiol
; 29(12): 7074-7075, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31278572
7.
An analysis of 11.3 million screening tests examining the association between needle biopsy rates and cancer detection rates in the English NHS Breast Cancer Screening Programme.
Clin Radiol
; 74(5): 384-389, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30799096
8.
Role of performance metrics in breast screening imaging - where are we and where should we be?
Clin Radiol
; 73(4): 381-388, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29395223
9.
Disability and participation in breast and bowel cancer screening in England: a large prospective study.
Br J Cancer
; 117(11): 1711-1714, 2017 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28972966
10.
Re: COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London. A reply.
Clin Radiol
; 76(6): 468-469, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33832702
11.
Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women.
Br J Cancer
; 112(9): 1562-7, 2015 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25742470
12.
Sustained efficacy of a single intra-articular dose of FX006 in a rat model of repeated localized knee arthritis.
Osteoarthritis Cartilage
; 23(1): 151-60, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25266960
13.
Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.
Br J Cancer
; 111(11): 2156-62, 2014 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-25225905
14.
Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme.
Br J Cancer
; 110(3): 560-4, 2014 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-24366303
15.
Longer mean colonoscopy withdrawal time is associated with increased adenoma detection: evidence from the Bowel Cancer Screening Programme in England.
Endoscopy
; 45(1): 20-6, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23254403
16.
An observational study to evaluate the performance of units using two radiographers to read screening mammograms.
Clin Radiol
; 67(2): 114-21, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22070944
17.
ABC3 Part II: a review of the new criteria for evaluating cervical cytology in England.
Cytopathology
; 23(6): 360-70, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23173805
18.
Estimation of disease severity in the NHS cervical screening programme. Part I: artificial cut-off points and semi-quantitative solutions.
Cytopathology
; 22(3): 146-54, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20946448
19.
Estimation of disease severity in the NHS cervical screening programme. Part II: quantitative methods of estimating disease severity and progression potential.
Cytopathology
; 22(3): 155-63, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20946449
20.
Using a graph of the abnormal predictive value versus the positive predictive value for the determination of outlier laboratories in the National Health Service cervical screening programme.
Cytopathology
; 21(6): 379-88, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20518798